Pancreatic Cancer Research

ResearcherUniversity of FoggiaActive in the last 2 years

Joaquina Martínez-Galán

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6814-2748; OpenAlex author ID A5079037921. Sources: OpenAlex.

Their work

Papers
14
Trials
0
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: 3 papers · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 14

  1. Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarc… Co-author DOI 10.1177/17588359241309828↗
  2. Potential clinical applications of extracellular vesicles in pancreatic cancer: exploring untapped opportunities from biomarkers to novel therapeutic approache… Co-author DOI 10.20517/evcna.2023.68↗
  3. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Co-author DOI 10.4251/wjgo.v15.i2.268↗
  4. Importance of BRCA mutation for the current treatment of pancreatic cancer beyond maintenance. Co-author DOI 10.3748/wjg.v27.i39.6515↗
  5. Liquid biopsy approach to pancreatic cancer. Co-author DOI 10.4251/wjgo.v13.i10.1263↗
  6. Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics. Co-author DOI 10.3390/cancers12041002↗
  7. Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cance… Co-author DOI 10.1200/jco.18.00089↗
  8. Proteomic biomarkers in body fluids associated with pancreatic cancer. Co-author DOI 10.18632/oncotarget.24654↗
  9. From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer. Co-author DOI 10.7150/jca.23716↗
  10. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain. Co-author DOI 10.1007/s12094-016-1594-x↗
  11. Pancreatic ductal adenocarcinoma: metastatic disease. Co-author DOI 10.1007/s12094-017-1690-6↗
  12. Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety … Co-author DOI 10.1016/j.ejca.2016.12.032↗
  13. The potential role of the glycoprotein osteoactivin/glycoprotein nonmetastatic melanoma protein B in pancreatic cancer. Co-author DOI 10.1097/mpa.0000000000000250↗
  14. Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. Co-author DOI 10.1155/2015/518284↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Octavio Caba · 5 shared papers, 2018–2023 · strength 0.80
  2. Carolina Torres · 5 shared papers, 2015–2024 · strength 0.59
  3. Cristina Jiménez‐Luna · 4 shared papers, 2018–2023 · strength 0.58
  4. Sonia Perales · 4 shared papers, 2015–2024 · strength 0.50
  5. Teresa Mercade Macarulla · 4 shared papers, 2017–2025 · strength 0.42
  6. Jose Manuel Sanchez-Manas · 2 shared papers, 2021–2024 · strength 0.41
  7. Jose Carlos Prados · 4 shared papers, 2015–2021 · strength 0.39
  8. Roberto Pazo-Cid · 4 shared papers, 2017–2025 · strength 0.38
  9. Rafael Álvarez-Gallego · 3 shared papers, 2017–2025 · strength 0.34
  10. Manuel M. Hidalgo · 4 shared papers, 2017–2019 · strength 0.30
  11. Pedro J. Real · 1 shared paper, 2024 · strength 0.26
  12. Andrés Jesús Muñoz Martín · 3 shared papers, 2017–2019 · strength 0.25
  13. Ismael Ghanem · 1 shared paper, 2025 · strength 0.21
  14. Antonio Cubillo · 1 shared paper, 2025 · strength 0.21
  15. Consolación Melguizo · 2 shared papers, 2018–2020 · strength 0.20
  16. Ruth Vera · 3 shared papers, 2017–2019 · strength 0.17
  17. Carmen Guillén‐Ponce · 3 shared papers, 2017–2019 · strength 0.17
  18. Mercedes Salgado · 2 shared papers, 2017–2018 · strength 0.13
  19. Alfredo Carrato · 2 shared papers, 2017–2018 · strength 0.13
  20. Fernando Rivera · 2 shared papers, 2017–2019 · strength 0.13
  21. José Pérez del Palacio · 1 shared paper, 2020 · strength 0.11
  22. Ariadna Martín-Blázquez · 1 shared paper, 2020 · strength 0.11
  23. Francisca Vicente · 1 shared paper, 2020 · strength 0.11
  24. Ana Linares · 2 shared papers, 2015 · strength 0.10
  25. Antonio Irigoyen · 2 shared papers, 2015–2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.